Physician
Alan F Dakak MD INC
Alan F Dakak MD INC was paid $12.91M by Medicaid between Jan 2018 and Dec 2024, across 93 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoALAN F DAKAK MD INC
BAKERSFIELD, CA 93301
BAKERSFIELD, CA 93301
33aNPI1780950543assigned 03/27/2012
33bProvider typePediatrics Physician
28Total paid$12.91M
24GClaims441,807
24DCodes billed93
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in California
Rank by total paid#14 of 1,490
Median peer was paid$15K
This provider vs. median861×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 77,454 | $1.76M | |
| 2019 | 67,715 | $1.77M | |
| 2020 | 53,034 | $1.42M | |
| 2021 | 61,191 | $1.62M | |
| 2022 | 68,314 | $1.96M | |
| 2023 | 61,058 | $1.74M | |
| 2024incomplete | 53,041 | $2.64M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 67,545 | 60,318 | $2.78M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 24,601 | 24,381 | $1.39M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.8% | 18,797 | 18,466 | $1.14M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.4% | 14,720 | 14,626 | $957K |
| 96156 | 7.2% | 16,643 | 16,465 | $925K | |
| G9920 | Screening performed and negative | 4.9% | 18,468 | 18,415 | $635K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.3% | 8,970 | 8,685 | $556K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.8% | 6,230 | 6,214 | $486K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.2% | 6,499 | 6,450 | $411K |
| 99460 | 2.8% | 5,794 | 5,763 | $359K | |
| 99381 | 2.2% | 3,861 | 3,772 | $279K | |
| 92551 | 2.0% | 20,608 | 20,436 | $260K |
81 more codes
| 90648 | 1.5% | 18,952 | $198K | |
| 90670 | 1.4% | 16,455 | $180K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 2,339 | $156K |
| 90723 | 1.2% | 14,962 | $155K | |
| 99188 | 1.2% | 7,223 | $152K | |
| 90686 | 1.2% | 13,838 | $149K | |
| 99462 | 1.0% | 3,990 | $129K | |
| 90680 | <1% | 11,496 | $123K | |
| 90633 | <1% | 10,139 | $110K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,102 | $105K |
| 90710 | <1% | 9,746 | $104K | |
| 99173 | <1% | 22,700 | $101K | |
| 99383 | <1% | 1,299 | $97K | |
| 83655 | <1% | 9,947 | $91K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,420 | $72K |
| 90651 | <1% | 5,580 | $67K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,116 | $65K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 4,101 | $51K |
| 90696 | <1% | 4,690 | $48K | |
| 90700 | <1% | 4,398 | $47K | |
| 99382 | <1% | 659 | $45K | |
| 85018 | <1% | 21,760 | $40K | |
| 87428 | <1% | 660 | $38K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 408 | $37K |
| 99384 | <1% | 370 | $34K | |
| 17110 | <1% | 331 | $31K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,238 | $27K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,765 | $27K |
| 88720 | <1% | 5,971 | $27K | |
| 90677 | <1% | 2,046 | $25K | |
| 90734 | <1% | 2,358 | $25K | |
| 90715 | <1% | 2,252 | $23K | |
| 90620 | <1% | 1,439 | $20K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 244 | $14K |
| 90619 | <1% | 1,115 | $12K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,892 | $12K |
| 90685 | <1% | 850 | $10K | |
| 90688 | <1% | 731 | $8K | |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 266 | $8K |
| 69210 | <1% | 225 | $8K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 2,461 | $6K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 119 | $5K |
| 51701 | <1% | 48 | $5K | |
| 41010 | <1% | 26 | $5K | |
| 99463 | <1% | 50 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 254 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 27 | $4K |
| 96150 | <1% | 1,236 | $4K | |
| 81002 | <1% | 2,093 | $3K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 168 | $3K |
| 96127 | <1% | 523 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 388 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 24 | $2K |
| 86580 | <1% | 454 | $2K | |
| 94664 | <1% | 93 | $1K | |
| 90621 | <1% | 69 | $986.25 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $946.68 |
| 90381 | <1% | 81 | $875.25 | |
| 99441 | <1% | 14 | $499.52 | |
| 96111 | <1% | 35 | $424.80 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 14 | $350.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 52 | $289.21 |
| 97802 | <1% | 196 | $180.00 | |
| 90707 | <1% | 24 | $175.50 | |
| 90713 | <1% | 13 | $146.25 | |
| 90380 | <1% | 15 | $135.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 47 | $132.00 |
| 90744 | <1% | 13 | $105.75 | |
| 81025 | <1% | 26 | $72.80 | |
| 90716 | <1% | 12 | $51.75 | |
| 90698 | <1% | 12 | $45.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 193 | $24.44 |
| 82962 | <1% | 12 | $20.00 | |
| 90672 | <1% | 14 | $18.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 105 | $17.01 |
| 94760 | <1% | 254 | $13.98 | |
| 96161 | <1% | 911 | $3.40 | |
| J7699 | Noc drugs, inhalation solution administered through dme | 0% | 106 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 180 | $0.00 |
| 91300 | 0% | 29 | $0.00 | |
| 3008F | 0% | 1,595 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAKAK, ALAN (PRESIDENT)